Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

METROPOLIS's revenues are expected to fall below last year's, and this forecast tends to raise concerns among investors. A revenue drop can negatively impact the company's profitability, making investors more cautious about their positions due to the risks of declining financial performance.

Financial Ratios:

currentRatio 0.000000
forwardPE 39.747753
debtToEquity 15.956000
earningsGrowth 0.153000
revenueGrowth 0.109000
grossMargins 0.778610
operatingMargins 0.137290
trailingEps 29.550000
forwardEps 0.000000

Metropolis Healthcare Limited's low Debt-to-Equity ratio shows the company avoids heavy reliance on debt. This balanced approach reduces financial risk, as it maintains a healthy equity position without excessive leverage, providing greater financial stability and flexibility.
METROPOLIS's positive earnings and revenue growth signal that the company is expected to expand its business. The company's increasing profits and sales reflect strong financial health, suggesting continued growth and success in the coming periods.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

Metropolis Healthcare Limited's price projections have gradually decreased, reflecting a less optimistic view of the company's future performance. Analysts are adjusting their expectations, suggesting potential concerns about Metropolis Healthcare Limited's ability to meet previous growth targets.

Insider Transactions:

Insider Transactions for METROPOLIS
Insider Transactions for METROPOLIS


2 sales transactions of METROPOLIS were conducted, with market price at 2095.9249267578125.During the review period, no sell transactions were executed.METROPOLIS is seeing more buys than sells at current price levels, which may indicate a positive market outlook. This trend suggests growing confidence among investors, who appear to expect favorable performance from the stock.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


A recent buy bias from analysts toward Metropolis Healthcare Limited may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that Metropolis Healthcare Limited might be an appealing option for those looking to grow their wealth through stock market investments.